Fundraising FoxPharmacyclics
4 known investors
Find your way into Pharmacyclics
Sign up to see every warm intro you have to Pharmacyclics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pharmacyclics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pharmacyclics, an AbbVie company, develops treatment options for cancer and immune-mediated diseases. It focuses on research and therapeutics for patients affected by these conditions.
Founders & leadership
Investors · 4
Asset Management Companylisted by Asset Management CompanyMenlo Park · $500K – $2M
How we know: Asset Management Company's portfolio page · Not right? Tell us
Kleiner Perkinslisted by Kleiner PerkinsMenlo Park · $500K – $15M
How we know: Kleiner Perkins's portfolio page · Not right? Tell us
Frequently asked questions
- What does Pharmacyclics do?
- Pharmacyclics, an AbbVie company, develops treatment options for cancer and immune-mediated diseases. It focuses on research and therapeutics for patients affected by these conditions.
- Who are Pharmacyclics's investors?
- Pharmacyclics's investors include Asset Management Company, Kleiner Perkins, Ridgeback Capital, Venrock.